Production (Stage)
VYNE Therapeutics Inc.
VYNE
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.51% | -34.03% | 354.33% | 278.51% | 184.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.00% | 9.98% | 87.78% | 178.11% | 59.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -12.96% | -31.34% | -19.40% |
| Total Current Assets | -39.14% | -32.85% | 319.94% | 264.89% | 173.22% |
|
|
|||||
| Total Current Assets | -39.14% | -32.85% | 319.94% | 264.89% | 173.22% |
| Net Property, Plant & Equipment | -6.11% | -0.48% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.34% | 49.31% | 44.70% | 36.05% | -43.20% |
| Total Assets | -38.45% | -31.51% | 295.48% | 247.16% | 159.98% |
|
|
|||||
| Total Accounts Payable | 26.44% | 63.17% | 456.70% | 289.65% | 26.24% |
| Total Accrued Expenses | 226.39% | 144.54% | 26.27% | 11.76% | -69.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -46.15% | -13.91% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 42.21% | 52.00% | -- | 79.63% | -- |
| Total Other Current Liabilities | 42.21% | 52.00% | -- | 79.63% | -- |
| Total Current Liabilities | 77.36% | 96.59% | 96.33% | 84.41% | -7.83% |
|
|
|||||
| Total Current Liabilities | 77.36% | 96.59% | 96.33% | 84.41% | -7.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00% |
| Total Liabilities | 47.98% | 65.58% | 63.12% | 53.23% | -5.96% |
|
|
|||||
| Common Stock & APIC | 0.37% | 0.41% | 12.34% | 12.37% | 12.39% |
| Retained Earnings | -6.05% | -5.76% | -4.96% | -4.19% | -4.35% |
| Treasury Stock & Other | -- | -23.08% | -- | -- | -- |
| Total Common Equity | -47.06% | -41.30% | 452.26% | 333.47% | 215.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.06% | -41.30% | 452.26% | 333.47% | 215.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -47.06% | -41.30% | 452.26% | 333.47% | 215.43% |
|
|
|||||